Table 8.6e

Immunosuppression Use for Maintenance

Prior to Discharge, 1995 to 2004

Recipients with Kidney-Pancreas Transplants

  Year of Transplant
1995 1996 1997 1998 1999 2000 2001 2002 2003 2004
Functioning Graft at Discharge 894 835 823 933 908 887 862 877 846 862
With Immunosuppression Info 893 835 823 933 908 885 861 877 843 829
Corticosteroids Any in Category 89.4% 96.2% 97.1% 96.8% 96.7% 96.4% 92.9% 88.7% 83.7% 75.8%
Steroids 89.4% 96.2% 97.1% 96.8% 96.7% 96.4% 92.9% 88.7% 83.7% 75.8%
Cyclosporine Any in Category 58.2% 59.0% 47.3% 31.3% 23.2% 18.9% 13.7% 9.8% 8.9% 6.4%
Cyclosporin 52.4% 5.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Sandimmmune 2.4% 7.5% 6.1% 3.1% 2.4% 1.9% 0.9% 0.8% 0.1% 0.1%
Neoral 3.5% 46.3% 41.2% 28.2% 20.7% 16.2% 10.8% 6.8% 7.2% 5.4%
Gengraf 0.0% 0.0% 0.0% 0.0% 0.1% 0.8% 2.0% 1.9% 1.5% 0.8%
Eon 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.2% 0.0% 0.0%
Tacrolimus Any in Category 36.6% 41.3% 56.4% 68.9% 75.0% 81.4% 86.6% 89.9% 83.9% 84.3%
Tacrolimus 36.6% 41.3% 56.4% 68.9% 75.0% 81.4% 86.6% 89.9% 83.9% 84.3%
Antimetabolites Any in Category 86.1% 91.5% 93.4% 93.8% 91.6% 84.5% 79.6% 82.0% 82.7% 84.2%
Mycophenolate Mofetil 22.2% 68.0% 84.3% 86.4% 88.4% 82.0% 78.5% 81.0% 81.6% 82.4%
Mycophenolate Sodium 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 1.4%
Azathioprine 63.8% 23.5% 9.0% 7.4% 3.2% 2.5% 1.0% 1.0% 1.1% 0.4%
Cytoxan 0.1% 0.0% 0.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
mTOR Inhibitors Any in Category 0.0% 0.0% 0.1% 0.5% 1.2% 13.1% 21.4% 18.8% 19.3% 16.6%
Sirolimus 0.0% 0.0% 0.1% 0.5% 1.0% 13.0% 21.4% 18.8% 19.2% 16.6%
Everolimus 0.0% 0.0% 0.0% 0.0% 0.2% 0.1% 0.0% 0.0% 0.1% 0.0%


Source: OPTN/SRTR Data as of May 2, 2005.

Individual drug percentages will not necessarily add up to the drug category percentages, as patients maybe prescribed more than one drug within the same category.